Does Depo-Provera Cause Headaches?
Yes, headache is a recognized adverse effect of Depo-Provera (medroxyprogesterone acetate). According to the FDA drug label, headache is listed as an established adverse reaction to this medication 1.
Evidence from FDA Drug Labeling
The official FDA prescribing information for Depo-Provera explicitly lists headache among the adverse reactions associated with this contraceptive 1. This represents the highest quality evidence available, as it reflects post-marketing surveillance and clinical trial data that informed regulatory approval.
Other adverse effects listed alongside headache include:
- Nervousness
- Dizziness
- Weight changes
- Menstrual irregularities (breakthrough bleeding, amenorrhea)
- Edema
Real-World Safety Data
A comprehensive pharmacovigilance analysis using the FDA Adverse Event Reporting System (FAERS) database from 2004-2024 provides additional confirmation 2. This large-scale real-world data analysis of 3,939 women using MPA as contraception documented headache as one of the reported adverse events, supporting the drug label findings.
Historical clinical studies from the 1970s-1990s also documented headache as a side effect during FDA approval processes 3, 4.
Clinical Implications
When counseling patients about Depo-Provera:
- Inform patients that headache is a known side effect that may occur with use
- Headaches typically occur alongside other common side effects like menstrual irregularities, weight gain, and nervousness
- The frequency and severity can vary between individuals
- If headaches are severe or persistent, patients should contact their provider to discuss whether to continue the method or switch to an alternative contraceptive
If a patient experiences intolerable headaches on Depo-Provera, offer counseling on alternative contraceptive methods and initiate another method if desired 5.
Important Caveat
While headache is a recognized side effect, severe or new-onset headaches—particularly those with neurological symptoms—warrant evaluation to rule out more serious conditions such as cerebrovascular events, which have been associated with progestin therapy 1.